Saint-Gobain, a Fortune 200 company in France that produces high-tech materials, has completed a manufacturing facility for advanced biotech products at Songdo Biocluster in the Incheon Free Economic Zone (IFEZ).
IFEZ Authority said on April 8 that Saint-Gobain Korea, a 100 percent subsidiary of Saint-Gobain, has started a full operation of the plant, which has a gross floor space of 10,330 square meters.
Saint-Gobain has invested a total of 22 billion won in the facility, which is built on a 9,663-square-meter site in Ki10 Block in Songdo High-tech Industrial Cluster in Incheon. The company broke ground for the plant in November 2018.
The facility has a bio fluid system production line. A fluid system refers to a product group that enables cell culture and raw materials to be moved and stored in a biomedical process. Saint-Gobain signed a land purchase contract in September 2018 with IFEZ.
Saint-Gobain was founded in France in 1665 and has been developing and producing products for ceramic materials and high-performance plastics for over 350 years. The company supplies its products to a wide range of the medical, aerospace, automotive, and semiconductor industries, including high-tech industries such as life science. It has 170,000 employees in 67 countries around the world.
“Saint-Gobain has significantly boosted the global status of Songdo Biocluster,” said Lee Won-jae, IFEZ Authority commissioner. "We will do our best to help tenant companies including Saint-Gobain grow. We will also make further efforts to attract investment from global companies."